SCTX 8-K 2026-09-02

Scribe Therapeutics, Inc. (SCTX) 8-K dated 2026-09-02 — accession 0001193125-26-380184. This URL is the filing, not the SCTX hub.

Scribe Therapeutics, Inc. (SCTX) common stock.

Scribe Therapeutics, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-380184.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SCTX revenue for 2026-06-30 was $4.2M. Net income was -$23.8M. Revenue was down 81.2% from 2025-06-30 to 2026-06-30.

Not investment advice. The SCTX SEC hub lists recent forms. The stock page is the research view.